Trial intelligence / Profile preview

Filgrastim in Alzheimer's Disease

NCT01617577Phase 2Completed

Sponsor
University of South Florida
Start
Jun 2009
Primary completion
Feb 2012
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of filgrastim in Alzheimer's disease (AD), sponsored by University of South Florida. Started Jun 2009; status: completed.

02

Drugs

filgrastim
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT01617577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01617577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call